Ton Andy, Bell Jennifer A, Karakash William J, Alter Thomas D, Erdman Mary Kate, Kang Hyunwoo Paco, Mills Emily S, Ragheb Jonathan Mina, Athari Mirbahador, Wang Jeffrey C, Alluri Ram K, Hah Raymond J
Department of Orthopaedic Surgery, Keck School of Medicine, The University of Southern California, Los Angeles, CA 90033, USA.
Department of Orthopaedic Surgery, Mayo Clinic, Rochester, MN 55905, USA.
J Clin Med. 2024 Aug 14;13(16):4781. doi: 10.3390/jcm13164781.
Vertebral compression fractures (VCFs) pose a considerable healthcare burden and are linked to elevated morbidity and mortality. Despite available anti-osteoporotic treatments (AOTs), guideline adherence is lacking. This study aims to evaluate subsequent hip fracture incidence after index VCF and to elucidate AOT prescribing patterns in VCF patients, further assessing the impact of surgical interventions on these patterns. Patients with index VCFs between 2010 and 2021 were identified using the PearlDiver database. Diagnostic and procedural data were recorded using International Classification of Diseases (ICD-9, ICD-10) and Current Procedural Terminology (CPT) codes. Patients under age 50 and follow-up <one year following index VCF were excluded. Patients were categorized based on whether they received AOT within one year, preceding and after index VCF, and were subsequently propensity-matched 1:3 based on age, sex, and Elixhauser Comorbidity Index (ECI) score to compare hip fracture incidence following index VCF. Sub-analysis was performed for operatively managed VCFs (kyphoplasty/vertebroplasty). Statistical tests included Chi-squared for categorical outcomes, and Kruskal-Wallis for continuous measures. Of 637,701 patients, 72.6% were female. The overall subsequent hip fracture incidence was 2.6% at one year and 12.9% for all-time follow-up. Propensity-matched analysis indicated higher subsequent hip fracture rates in patients initiated on AOT post-index VCF (one year: 3.8% vs. 3.5%, = 0.0013; all-time: 14.3% vs. 13.0%, < 0.0001). The study reveals an unexpected increase in subsequent hip fractures among patients initiated on AOT post-index VCF, likely due to selection bias. These findings highlight the need for refined osteoporosis-management strategies to improve guideline adherence, thereby mitigating patient morbidity and mortality.
椎体压缩骨折(VCF)带来了相当大的医疗负担,并与发病率和死亡率的升高相关。尽管有可用的抗骨质疏松治疗(AOT),但指南依从性仍不足。本研究旨在评估初次VCF后随后的髋部骨折发生率,并阐明VCF患者的AOT处方模式,进一步评估手术干预对这些模式的影响。使用PearlDiver数据库识别2010年至2021年间发生初次VCF的患者。使用国际疾病分类(ICD - 9、ICD - 10)和当前程序术语(CPT)代码记录诊断和程序数据。排除年龄在50岁以下以及初次VCF后随访时间<1年的患者。根据患者在初次VCF之前和之后1年内是否接受AOT进行分类,并随后根据年龄、性别和埃利克斯豪泽合并症指数(ECI)得分进行1:3倾向匹配,以比较初次VCF后髋部骨折的发生率。对接受手术治疗的VCF(椎体后凸成形术/椎体成形术)进行亚分析。统计检验包括用于分类结果的卡方检验和用于连续测量的Kruskal - Wallis检验。在637,701名患者中,72.6%为女性。随后的髋部骨折总体发生率在1年时为2.6%,在所有随访期间为12.9%。倾向匹配分析表明,初次VCF后开始接受AOT的患者随后的髋部骨折发生率更高(1年时:3.8%对3.5%,P = 0.0013;所有随访期间:14.3%对13.0%,P < 0.0001)。该研究揭示了初次VCF后开始接受AOT的患者随后髋部骨折意外增加,可能是由于选择偏倚。这些发现凸显了需要完善骨质疏松管理策略以提高指南依从性,从而降低患者的发病率和死亡率。